← Open Payments lookup

SAM HAWKINS: Open Payments

NPI 1912695487 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,012 in 117 payments from 17 companies in 2025. Trend: 2023 $916 · 2024 $1,871 · 2025 $3,012

Food & beverage: $3,012
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.22$490
Neurocrine BioSciences, Inc.9$474
ABBVIE INC.11$390
Alkermes, Inc.10$257
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$240
Vanda Pharmaceuticals Inc.8$232
Janssen Pharmaceuticals, Inc5$115
E.R. Squibb & Sons, L.L.C.5$108
Almatica Pharma LLC6$102
Takeda Pharmaceuticals U.S.A., Inc.4$98

Products named: REXULTI, INGREZZA, VRAYLAR, ARISTADA, CAPLYTA, FANAPT, COBENFY, LOREEV XR.

Industry payments across NV — which companies pay providers there.